Elanco Animal Health Inc - COMMON STOCK (ELAN)

Historical Holders from Q1 2016 to Q3 2025

Symbol
ELAN on NYSE
CUSIP
28414H103
Type / Class
Equity / COMMON STOCK
Shares outstanding
493M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
571M
Holdings value
$11.5B
% of all portfolios
0.007%
Grand Portfolio weight change
+0.001%
Number of holders
392
Number of buys
228
Number of sells
-144
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Elanco Animal Health Inc - COMMON STOCK (ELAN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 13.1% +31% $626M $148M 64.9M +31% FMR LLC Jun 30, 2025
BlackRock, Inc. 8.9% +113% $887M $443M 44M +99.9% BlackRock, Inc. Sep 30, 2025
T. Rowe Price Investment Management, Inc. 6.4% $635M 31.5M T. Rowe Price Investment Management, Inc. Sep 30, 2025

Institutional Holders of Elanco Animal Health Inc - COMMON STOCK (ELAN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 571M $11.5B +$668M $20.14 392
2025 Q2 538M $7.69B +$656M $14.28 360
2025 Q1 494M $5.19B +$2M $10.50 358
2024 Q4 489M $5.93B +$69.6M $12.11 385
2024 Q3 478M $7.02B -$80.6M $14.69 385
2024 Q2 482M $6.96B +$62.8M $14.43 398
2024 Q1 476M $7.75B -$13M $16.28 372
2023 Q4 2.49M $37.2M -$338K $14.90 3
2023 Q3 477M $5.36B +$118M $11.24 342
2023 Q2 467M $4.7B -$72.1M $10.06 339
2023 Q1 476M $4.46B -$90M $9.40 376
2022 Q4 476M $5.84B +$244M $12.22 389
2022 Q3 460M $5.72B -$116M $12.41 388
2022 Q2 451M $8.85B -$83.7M $19.63 410
2022 Q1 472M $12.3B -$35.5M $26.09 449
2021 Q4 472M $13.4B +$167M $28.38 454
2021 Q3 442M $14.1B -$90.2M $31.89 435
2021 Q2 437M $15.2B +$247M $34.69 460
2021 Q1 433M $12.7B +$163M $29.45 427
2020 Q4 426M $13.1B +$1.14B $30.67 417
2020 Q3 409M $11.4B +$507M $27.93 341
2020 Q2 395M $8.48B -$186M $21.45 349
2020 Q1 400M $8.96B +$568M $22.39 343
2019 Q4 368M $10.8B -$50.8M $29.45 385
2019 Q3 370M $9.84B -$152M $26.59 353
2019 Q2 375M $12.7B +$596M $33.80 361
2019 Q1 374M $12B +$9.24B $32.07 339
2018 Q4 84.7M $2.67B +$416M $31.53 160
2018 Q3 71.1M $2.46B +$2.46B $34.89 151
2016 Q1 186 $6K $0 $32.26 1